Latest Articles
Endometriosis Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Yahoo Finance
Endometriosis Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight Yahoo Finance
Published: Jan. 22, 2026, 6 p.m.
Six Nations: Thibaud Flament to miss France vs Ireland Six Nations Test to attend wife's fertility treatment - Sky Sports
Six Nations: Thibaud Flament to miss France vs Ireland Six Nations Test to attend wife's fertility treatment Sky Sports
Published: Jan. 22, 2026, 5:34 p.m.
Thibaud Flament will miss France's Six Nations Test vs Ireland as it clashes with his wife's ART fertility treatment - Sky Sports
Thibaud Flament will miss France's Six Nations Test vs Ireland as it clashes with his wife's ART fertility treatment Sky Sports
Published: Jan. 22, 2026, 5:34 p.m.
France star to miss Ireland game to be with wife for fertility treatment - Irish Mirror
France star to miss Ireland game to be with wife for fertility treatment Irish Mirror
Published: Jan. 22, 2026, 4:52 p.m.
France star to miss Ireland game to be with wife for fertility treatment - irishmirror.ie
France star to miss Ireland game to be with wife for fertility treatment irishmirror.ie
Published: Jan. 22, 2026, 4:52 p.m.
Laois Senator Welcomes Ministerial Approval For Improved Endometriosis Services - Midlands 103
Laois Senator Welcomes Ministerial Approval For Improved Endometriosis Services Midlands 103
Published: Jan. 22, 2026, 4:48 p.m.
Laois Senator Welcomes Ministerial Approval For Improved Endometriosis Services - midlands103.com
Laois Senator Welcomes Ministerial Approval For Improved Endometriosis Services midlands103.com
Published: Jan. 22, 2026, 4:48 p.m.
NHS Online to offer video appointments for nine common conditions - AOL.com
NHS Online to offer video appointments for nine common conditions AOL.com
Published: Jan. 22, 2026, 4:08 p.m.
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer - Targeted Oncology
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer Targeted Oncology
Published: Jan. 22, 2026, 4:02 p.m.
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer - targetedonc.com
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer targetedonc.com
Published: Jan. 22, 2026, 4:02 p.m.
Link copied to clipboard!